World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
35492
World Ranking
9621
National Ranking
4959

Overview

Raymond Alexanian is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans several fields of study, with a primary focus on Medicine, supported by contributions in Biochemistry, Genetics, and Molecular Biology.

The scientist's work addresses important subfields including Hematology, Molecular Biology, Genetics, and Oncology. Their investigations notably cover topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Peptidase Inhibition and Analysis.

Their recent scholarly output includes publications in venues such as Blood Cancer Journal and UNC Libraries. Notable papers authored or co-authored by them are:

  • Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up, 2021, Blood Cancer Journal
  • A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma, 2021, UNC Libraries

Raymond Alexanian has collaborated frequently with other researchers in their field. Frequent co-authors include:

  • Robert Z. Orlowski
  • Elisabet E. Manasanch
  • Chutima Kunacheewa
  • Catherine M. Claussen
  • Hans C. Lee

Best Publications

  • A phase 2 study of bortezomib in relapsed, refractory myeloma.

    Paul G. Richardson;Bart Barlogie;James Berenson;Seema Singhal

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

    S. Jagannath;B. Barlogie;J. Berenson;D. Siegel

  • Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

    Bart Barlogie;Lon Smith;Raymond Alexanian

  • Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma

    Donna M Weber;Kim Rankin;Maria Gavino;Kay Delasalle

  • Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.

    Raymond Alexanian;Arthur Haut;Asad U. Khan;Montague Lane

  • Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

    Paul G. Richardson;Hannah Briemberg;Sundar Jagannath;Patrick Y. Wen

  • Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap

  • The Treatment of Multiple Myeloma

    Raymond Alexanian;Meletios Dimopoulos

  • Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Jordan U. Gutterman;Seymour Fine;Jorge Quesada;Sandra J. Horning

  • Primary dexamethasone treatment of multiple myeloma.

    Raymond Alexanian;Meletios A. Dimopoulos;Kay Delasalle;Bart Barlogie

  • Solitary plasmacytoma of bone and asymptomatic multiple myeloma.

    Meletios A. Dimopoulos;Lia A. Moulopoulos;Lia A. Moulopoulos;Lia A. Moulopoulos;Alice Maniatis;Alice Maniatis;Alice Maniatis;Raymond Alexanian;Raymond Alexanian;Raymond Alexanian

  • High-dose melphalan with autologous bone marrow transplantation for multiple myeloma.

    Bart Barlogie;Roy Hall;Axel Zander;Karel Dicke

  • Plasma cell myeloma--new biological insights and advances in therapy.

    Bart Barlogie;Joshua Epstein;Peter Selvanayagam;Raymond Alexanian

  • VAD-based regimens as primary treatment for multiple myeloma.

    Raymond Alexanian;Bart Barlogie;Susan Tucker

  • Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

    Robert A. Kyle;Steven P. Treon;Raymond Alexanian;Bart Barlogie

  • Nuclear factor–κB and STAT3 are constitutively active in CD138+cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

    Alok C. Bharti;Shishir Shishodia;James M. Reuben;Donna Weber

  • Renal failure in multiple myeloma. Pathogenesis and prognostic implications.

    Raymond Alexanian;Bart Barlogie;Dennis Dixon

  • Waldenstrom's macroglobulinemia

    MA Dimopoulos;R Alexanian

  • High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma

    Bail Barlogie;Raymond Alexanian;Karel A. Dicke;Gunar Zagars

Frequent Co-Authors

Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Jordan U. Gutterman
Jordan U. Gutterman The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Sundar Jagannath
Sundar Jagannath Icahn School of Medicine at Mount Sinai
Robert A. Kyle
Robert A. Kyle Mayo Clinic
Kenneth C. Anderson
Kenneth C. Anderson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several related degree options and career pathways that you can also explore online. These programs offer flexibility for working professionals, career changers, or those wishing to expand their healthcare expertise.

For those interested in the business and leadership side of healthcare, a healthcare administration degree can open doors to management roles in hospitals, clinics, and public health organizations. Licensed nurses aiming to advance clinical and leadership skills might consider adn to msn bridge programs for a streamlined educational path from associate to master’s level credentials.

Nutrition is another essential aspect of healthcare, and a nutritionist online degree prepares students for careers in dietetics, wellness coaching, and community health. Those seeking executive positions may be interested in cahme accredited online mha programs, which are recognized for their rigorous standards and value in the healthcare industry.

Exploring these related degrees can help you find the right fit for your career goals in the rapidly evolving healthcare sector.

Best Scientists Citing Raymond Alexanian

Trending Scientists